Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs
0 7 mins 2 yrs

Pfizer beats earnings estimates, hikes full-year outlook as drugmaker cuts costs

Kena Betancur | Corbis News | Getty Images Pfizer on Tuesday reported second-quarter revenue and adjusted earnings that blew past expectations and raised its full-year outlook, benefiting from its broad cost-cutting program, better-than-expected sales of its Covid antiviral pill, Paxlovid, and strong non-Covid product sales. The company […]

Health